These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16557007

  • 1. [RNA viruses and mutations].
    Sato H, Yokoyama M.
    Uirusu; 2005 Dec; 55(2):221-9. PubMed ID: 16557007
    [Abstract] [Full Text] [Related]

  • 2. RNA Viruses and RNAi: Quasispecies Implications for Viral Escape.
    Presloid JB, Novella IS.
    Viruses; 2015 Jun 19; 7(6):3226-40. PubMed ID: 26102581
    [Abstract] [Full Text] [Related]

  • 3. Stealth nucleosides: mode of action and potential use in the treatment of viral diseases.
    Daifuku R.
    BioDrugs; 2003 Jun 19; 17(3):169-77. PubMed ID: 12749753
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure.
    Le Nouën C, McCarty T, Brown M, Smith ML, Lleras R, Dolan MA, Mehedi M, Yang L, Luongo C, Liang B, Munir S, DiNapoli JM, Mueller S, Wimmer E, Collins PL, Buchholz UJ.
    Proc Natl Acad Sci U S A; 2017 Jan 17; 114(3):E386-E395. PubMed ID: 28049853
    [Abstract] [Full Text] [Related]

  • 7. Impact of RNA virus infection on plant cell function and evolution.
    Niehl A, Heinlein M.
    Ann N Y Acad Sci; 2009 Oct 17; 1178():120-8. PubMed ID: 19845632
    [Abstract] [Full Text] [Related]

  • 8. VIRAPOPS: a forward simulator dedicated to rapidly evolved viral populations.
    Petitjean M, Vanet A.
    Bioinformatics; 2014 Feb 15; 30(4):578-80. PubMed ID: 24336644
    [Abstract] [Full Text] [Related]

  • 9. A focus on RNA viruses.
    Woodland DL.
    Viral Immunol; 2011 Apr 15; 24(2):67-8. PubMed ID: 21449716
    [No Abstract] [Full Text] [Related]

  • 10. How does the genome structure and lifestyle of a virus affect its population variation?
    Safari M, Roossinck MJ.
    Curr Opin Virol; 2014 Dec 15; 9():39-44. PubMed ID: 25243801
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of innate immune evasion in re-emerging RNA viruses.
    Ma DY, Suthar MS.
    Curr Opin Virol; 2015 Jun 15; 12():26-37. PubMed ID: 25765605
    [Abstract] [Full Text] [Related]

  • 12. High fidelity simian immunodeficiency virus reverse transcriptase mutants have impaired replication in vitro and in vivo.
    Lloyd SB, Lichtfuss M, Amarasena TH, Alcantara S, De Rose R, Tachedjian G, Alinejad-Rokny H, Venturi V, Davenport MP, Winnall WR, Kent SJ.
    Virology; 2016 May 15; 492():1-10. PubMed ID: 26896929
    [Abstract] [Full Text] [Related]

  • 13. RNA virus quasispecies: significance for viral disease and epidemiology.
    Duarte EA, Novella IS, Weaver SC, Domingo E, Wain-Hobson S, Clarke DK, Moya A, Elena SF, de la Torre JC, Holland JJ.
    Infect Agents Dis; 1994 Aug 15; 3(4):201-14. PubMed ID: 7827789
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effects of population bottlenecks in an RNA virus evolving at increased error rate.
    Cases-González C, Arribas M, Domingo E, Lázaro E.
    J Mol Biol; 2008 Dec 31; 384(5):1120-9. PubMed ID: 18951905
    [Abstract] [Full Text] [Related]

  • 15. Parvovirus variation for disease: a difference with RNA viruses?
    López-Bueno A, Villarreal LP, Almendral JM.
    Curr Top Microbiol Immunol; 2006 Dec 31; 299():349-70. PubMed ID: 16568906
    [Abstract] [Full Text] [Related]

  • 16. Mutational robustness and resilience of a replicative cis-element of RNA virus: Promiscuity, limitations, relevance.
    Prostova MA, Gmyl AP, Bakhmutov DV, Shishova AA, Khitrina EV, Kolesnikova MS, Serebryakova MV, Isaeva OV, Agol VI.
    RNA Biol; 2015 Dec 31; 12(12):1338-54. PubMed ID: 26488412
    [Abstract] [Full Text] [Related]

  • 17. The VIZIER project: preparedness against pathogenic RNA viruses.
    Coutard B, Gorbalenya AE, Snijder EJ, Leontovich AM, Poupon A, De Lamballerie X, Charrel R, Gould EA, Gunther S, Norder H, Klempa B, Bourhy H, Rohayem J, L'hermite E, Nordlund P, Stuart DI, Owens RJ, Grimes JM, Tucker PA, Bolognesi M, Mattevi A, Coll M, Jones TA, Aqvist J, Unge T, Hilgenfeld R, Bricogne G, Neyts J, La Colla P, Puerstinger G, Gonzalez JP, Leroy E, Cambillau C, Romette JL, Canard B.
    Antiviral Res; 2008 Apr 31; 78(1):37-46. PubMed ID: 18083241
    [Abstract] [Full Text] [Related]

  • 18. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK, Hirsch MS, Merrill DP, Bechtel LJ, Eron JJ, Kaplan JC, D'Aquila RT.
    Nature; 1993 Feb 18; 361(6413):650-4. PubMed ID: 7679778
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.